That's a turn around on your part, and long overdue
I've always been on the record as supporting this. Trade US rights for cash and a %royalty. Keep ROW. Eventually sell ROW and US royalty % en bloc, hopefully to the same entity that buys the US rights. Immediate cash in bank, no need for further cap raises and sp rises and immediate start on FDA by a committed partner.
You've always been negative about it.
OSL will never have the capital to undertake pivotal US FDA trials for ca pancreas.
That's a turn around on your part, and long overdueI've always...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
-0.025(2.46%) |
Mkt cap ! $13.51M | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.05 | 95.0¢ | $59.46K | 61.97K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 1875 | 1 |
View Market Depth
| Last trade - 13.27pm 19/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |